Oral supplementation with probiotic L. reuteri NCIMB 30242 increases mean circulating 25-hydroxyvitamin D: A post hoc analysis of a randomized controlled trial

Journal of Clinical Endocrinology and Metabolism

Volumn 98, Issue 7, 2013, Pages 2944-2951

  Jones, Mitchell L ^a,b   Martoni, Christopher J ^b   Prakash, Satya ^a,b  

^a MCGILL UNIVERSITY   (Canada)

^b Micropharma Limited   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

25 HYDROXYVITAMIN D; ALPHA TOCOPHEROL; BETA CAROTENE; CARDIOVIVA; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PLACEBO; PROBIOTIC AGENT; RETINOL; TRIACYLGLYCEROL; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; BODY MASS; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DIET SUPPLEMENTATION; DIETARY INTAKE; DOUBLE BLIND PROCEDURE; DRUG EFFECT; DRUG RESPONSE; FEMALE; GASTROINTESTINAL ABSORPTION; HUMAN; HYPERCHOLESTEROLEMIA; LACTOBACILLUS REUTERI; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; NUTRITIONAL STATUS; OUTCOME ASSESSMENT; POST HOC ANALYSIS; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; TREATMENT DURATION; TRIACYLGLYCEROL BLOOD LEVEL; VITAMIN BLOOD LEVEL;

25-HYDROXYVITAMIN D 2; ADULT; AGED; AMIDOHYDROLASES; ANTICHOLESTEREMIC AGENTS; BACTERIAL PROTEINS; CALCIFEDIOL; CHOLESTEROL, LDL; CZECH REPUBLIC; DOUBLE-BLIND METHOD; FEMALE; HUMANS; HYPERCHOLESTEROLEMIA; INTESTINAL ABSORPTION; LACTOBACILLUS REUTERI; MALE; MIDDLE AGED; PROBIOTICS; VITAMIN D; VITAMIN D DEFICIENCY; YOUNG ADULT;

LACTOBACILLUS REUTERI;

EID: 84879981844     PISSN: 0021972X     EISSN: 19457197     Source Type: Journal    
DOI: 10.1210/jc.2012-4262     Document Type: Article

References (37)

1. Gupta A, Bush A, Hawrylowicz C, Saglani S. Vitamin d and asthma in children. Paediatr Respir Rev. 2012;13(4):236-243; quiz 243.
2. Holick MF. VitaminDdeficiency. NEngl J Med. 2007;357(3):266-281.
3. Bischoff-Ferrari HA, Shao A, Dawson-Hughes B, Hathcock J, Giovannucci E, Willett WC. Benefit-risk assessment of vitamin D supplementation. Osteoporos Int. 2010;21(7):1121-1132.
4. Wang TJ, Pencina MJ, Booth SL, et al. VitaminDdeficiency and risk of cardiovascular disease. Circulation. 2008;117(4):503-511.
5. Pittas AG, Lau J, Hu FB, Dawson-Hughes B. The role of vitamin D and calcium in type 2 diabetes. A systematic review and meta-analysis. J Clin Endocrinol Metab. 2007;92(6):2017-2029. (Pubitemid 46997093)
6. Jenab M, Bueno-de-Mesquita HB, Ferrari P, et al. Association between pre-diagnostic circulating vitaminDconcentration and risk of colorectal cancer in European populations:a nested case-control study. BMJ. 2010;340:b5500.
7. Institue of Medicine Dietary Reference Intakes for Calcium and Vitamin D. Washington, DC: National Academies Press; 2010.
8. Pilz S, Tomaschitz A, Marz W, et al. Vitamin D, cardiovascular disease and mortality. Clin Endocrinol (Oxf). 2011;75(5):575-584.
9. Souberbielle JC, Body JJ, Lappe JM, et al. Vitamin D and musculoskeletal health, cardiovascular disease, autoimmunity and cancer: recommendations for clinical practice. Autoimmun Rev. 2010;9(11):709-715.
10. Li L, Yin X, Yao C, Zhu X,WuX. Vitamin D, parathyroid hormone and their associations with hypertension in a Chinese population. PLoS One. 2012;7(8):e43344.
11. Kilkkinen A, Knekt P, Aro A, et al. Vitamin D status and the risk of cardiovascular disease death. Am J Epidemiol. 2009;170(8):1032-1039.
12. Anderson JL, May HT, Horne BD, et al. Relation of vitamin D deficiency to cardiovascular risk factors, disease status, and incident events in a general healthcare population. Am J Cardiol. 2010;106(7):963-968.
13. Schleithoff SS, Zittermann A, Tenderich G, Berthold HK, Stehle P, Koerfer R. Vitamin D supplementation improves cytokine profiles in patients with congestive heart failure: a double-blind, randomized, placebo-controlled trial. Am J Clin Nutr. 2006;83(4):754-759. (Pubitemid 44713136)
14. O'Connell TD, Berry JE, Jarvis AK, Somerman MJ, Simpson RU. 1,25-Dihydroxyvitamin D3 regulation of cardiac myocyte proliferation and hypertrophy. Am J Physiol. 1997;272(4 Pt 2):H1751-H1758.
15. Li YC, Qiao G, Uskokovic M, Xiang W, Zheng W, Kong J. Vitamin D: a negative endocrine regulator of the renin-angiotensin system and blood pressure. J Steroid Biochem Mol Biol. 2004;89-90(1-5):387-392.
16. Yoon SS, Sun J. Probiotics, nuclear receptor signaling, and antiinflammatory pathways. Gastroenterol Res Pract. 2011;2011:971938.
17. Koren O, Goodrich JK, Cullender TC, et al. Host remodeling of the gut microbiome and metabolic changes during pregnancy. Cell. 2012;150(3):470-480.
18. Lee J,MoJH, Katakura K, et al. Maintenance of colonic homeostasis by distinctive apicalTLR9signalling in intestinal epithelial cells. Nat Cell Biol. 2006;8(12):1327-1336.
19. Duboc H, Rajca S, Rainteau D, et al. Connecting dysbiosis, bile-acid dysmetabolism and gut inflammation in inflammatory bowel diseases. Gut. 2013;62(4):531-539.
20. Ley RE. Obesity and the human microbiome. Curr Opin Gastroenterol. 2010;26(1):5-11.
21. Ly NP, Litonjua A, Gold DR, Celedón JC. Gut microbiota, probiotics, and vitamin D: interrelated exposures influencing allergy, asthma, and obesity? J Allergy Clin Immunol. 2011;127(5):1087-1094.
22. Kong J, Zhang Z, Musch MW, et al. Novel role of the vitamin D receptor in maintaining the integrity of the intestinal mucosal barrier. Am J Physiol Gastrointest Liver Physiol. 2008;294(1):G208-G216.
23. FAO/World Health Organization. Health and Nutritional Properties of Probiotics in Food Including Powder Milk with Live Lactic Acid Bacteria; Report of a JointFAO/WHOExpert Consultation on Evaluation of Health and Nutritional Properties of Probiotics in Food Including Power Milk with Live Lactic Acid Bacteria. American Córdoba Park Hotel, Córdoba, Argentina, October 1-4, 2001.
24. Pérez-Castrillón JL, Vega G, Abad L, et al. Effects of atorvastatin on vitamin D levels in patients with acute ischemic heart disease. Am J Cardiol. 2007;99(7):903-905. (Pubitemid 46483276)
25. Rejnmark L, Vestergaard P, Heickendorff L, Mosekilde L. Simvastatin does not affect vitamin d status, but low vitamin d levels are associated with dyslipidemia: results from a randomised, controlled trial. Int J Endocrinol. 2010;2010:957174.
26. Jones ML, Martoni CJ, Parent M, Prakash S. Cholesterol-lowering efficacy of a microencapsulated bile salt hydrolase-active Lactobacillus reuteri NCIMB 30242 yoghurt formulation in hypercholesterolaemic adults. Br J Nutr. 2012;107(10):1505-1513.
27. Jones ML, Martoni CJ, Prakash S. Cholesterol lowering and inhibition of sterol absorption by Lactobacillus reuteri NCIMB 30242: a randomized controlled trial. Eur J Clin Nutr. 2012;66(11):1234-1241.
28. National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. Circulation. 2002;106(25):3143-3421.
29. Miettinen TA, Gylling H, Nissinen MJ. The role of serum non-cholesterol sterols as surrogate markers of absolute cholesterol synthesis and absorption. Nutr Metab Cardiovasc Dis. 2011;21(10):765-769.
30. Golan DE, Tashjian AH, Armstrong EJ, Armstrong AW. Principles of Pharmacology: The Pathophysiologic Basis of Drug Therapy. 2nd ed. Philadelphia, PA: Lippincott Williams, Wilkins; 2008.
31. Hollander D, Muralidhara KS, Zimmerman A. Vitamin D-3 intestinal absorption in vivo: influence of fatty acids, bile salts, and perfusate pH on absorption. Gut. 1978;19(4):267-272. (Pubitemid 8324286)
32. Guryev O, Carvalho RA, Usanov S, Gilep A, Estabrook RW. A pathway for the metabolism of vitamin D3: unique hydroxylated metabolites formed during catalysis with cytochrome P450scc (CYP11A1). Proc Natl Acad Sci U S A. 2003;100(25):14754-14759. (Pubitemid 37517963)
33. Yavuz B, Ertugrul DT, Cil H, et al. Increased levels of 25 hydroxyvitamin D and 1,25-dihydroxyvitaminDafter rosuvastatin treatment: a novel pleiotropic effect of statins? Cardiovasc Drugs Ther. 2009;23(4):295-299.
34. Ness GC, Holland RC, Lopez D. Selective compensatory induction of hepatic HMG-CoA reductase in response to inhibition of cholesterol absorption. Exp Biol Med (Maywood). 2006;231(5):559-565.
35. Cross HS, Nittke T, Kallay E. Colonic vitamin D metabolism: implications for the pathogenesis of inflammatory bowel disease and colorectal cancer. Mol Cell Endocrinol. 2011;347(1-2):70-79.
36. Jones ML, Martoni CJ, Prakash S. Letter to the editor regarding the report of Duboc et al: connecting dysbiosis, bile-acid dysmetabolism and gut inflammation in inflammatory bowel disease. Gut. 2013;62(4):654-655.
37. Snijder MB, Lips P, Seidell JC, et al. Vitamin D status and parathyroid hormone levels in relation to blood pressure: a populationbased study in older men and women. J Intern Med. 2007;261(6):558-565. (Pubitemid 46835978)